SenoRx
Irvine
About SenoRx
SenoRx, Inc. was formerly known as BiopSolation Medical, Inc. and changed its name to SenoRx, Inc. in April 1998. The company was incorporated in 1998 and is headquartered in Irvine, California. As of July 6, 2010, SenoRx, Inc. operates as a subsidiary of Bard Peripheral Vascular, Inc. They develop, manufacture and sell minimally-invasive medical devices for the diagnosis of breast cancer. Their initial product focus has been biopsy systems and breast tissue markers. They also are developing products for use in the treatment of breast cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Total funding: $19.0M
- Funding stage: M&A
- Last round: Series Unknown (May 2001)
- Ticker: nasdaq:SENO
- Website: bardbiopsy.com
- Phone: +1 949-362-4800
Industries & Categories
Biotechnology, Health Care, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/senorx-2953583 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.